Synthesis 1990; 1990(5): 411-415
DOI: 10.1055/s-1990-26890
paper
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Synthesis of 2′,3′-Didehydro-2′,3′-dideoxyformycin A, 2prime;,3′-Dideoxyformycin A and 2′,3′-Dideoxytubercidin

Pawel Serafinowski*
  • *Drug Development Section, Cancer Research Campaign Laboratories, Institute of Cancer Research, Cotswold Road, Sutton, Surrey, SM2 5NG, England
Further Information

Publication History

Publication Date:
17 September 2002 (online)

2′,3′-Didehydro-2′,3′-dideoxyformycin A (7) was prepared by reaction of the 7-amino-3-[5-O-(2-acetoxyisobutyryl)-3-bromo -3-deoxy-2-O-phenoxy(thiocarbonyl)-β-D-xylofuranosyl]-1 H-pyrazolo [4,3-d]-pyrimidine (5) or 7-amino-3-[5-O-(2-acetoxyisobutyryl)-2-bromo-2-deoxy -3-O-phenoxy(thiocarbonyl)-β-D-arabinofuranosyl]-1H-pyrazolo[4, 3-d]pyrimidine (9) with tributyltin hydride and subsequent deprotection of the resulting 5′-O-(2-acetoxyisobutyryl)-2′, 3′-didehydro-2′,3′-dideoxyformycin A (6). 2′,3′-Dideoxyformycin A (13) and 2′,3′-dideoxytubercidin (16) were synthesized via deoxygenation of their respective 3′-deoxy counterparts 10 and 2, respectively.

    >